If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

SSRI medications have come under scrutiny as of late, despite medical experts maintaining they're safe and effective.

Cybin will leverage Osmind's 800-clinic network, point-of-care software, and real-world data to support the commercial preparation for its clinical-stage pipeline - ...

Other antidepressants usually prescribed for depression, according to NYU Langone Health, include serotonin-norepinephrine reuptake inhibitors such as venlafaxine and duloxetine and atypical ...

AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...

For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages of up to 120 mg daily have been studied. [25] Higher dosages do not have proven benefit and may ...

In addition to its pipeline candidates, Axsome also has US rights to Jazz Pharma's dual-acting dopamine and norepinephrine reuptake inhibitor Sunosi (solriamfetol), used to improve wakefulness in ...

A PTSD diagnosis also includes some different non-fear-based symptoms that aren't part of the acute stress disorder diagnosis ...

Results were announced from a phase 3 trial evaluating solriamfetol for major depressive disorder with/without severe excessive daytime sleepiness.